Alcon

Alcon Completes Acquisition of Aerie Pharmaceuticals

Alcon announced that it has completed its acquisition of Aerie Pharmaceuticals (Aerie).

Through the transaction, Alcon has added the commercial products Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% and Rhopressa (netarsudil ophthalmic solution) 0.02%, as well as AR-15512, a Phase 3 product candidate for dry eye disease. Alcon has also acquired a pipeline of ophthalmic pharmaceutical product candidates with the opportunity to leverage Aerie’s existing research and development capabilities.

“As we welcome the Aerie team to Alcon, we look forward to leveraging our expanding commercial footprint and expertise to bring Rocklatan® and Rhopressa® to even more customers and their patients,” said David Endicott, CEO of Alcon.

The transaction complements Alcon’s expansion into the ophthalmic pharmaceutical space, including acquisitions of the exclusive U.S. commercialization rights for Simbrinza® from Novartis in April 2021 and Eysuvis® and Inveltys® from Kala Pharmaceuticals, Inc. in May 2022.

Alcon intends to fully integrate Aerie into its business. As previously disclosed, the Company has used debt to fund the transaction for a total purchase consideration of approximately $930 million.

Click HERE for the full press release.

Featured Posts

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read More

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read More

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read More

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read More

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more